8.5.3 Late-Stage Pipeline Candidates 136 8.5.4 Comparative Efficacy and Safety Heat Map for Marketed and Pipeline Products 137 8.5.5 Pipeline Analysis 137 8.5.6 Forecasting Model 138 8.5.7 Deals Data Analysis 139 8.6 Contact Us 139 8.7 Disclaimer 139
List of Tables Table 1 : 2010 ACR-EULAR Classification Criteria for Rheumatoid Arthritis 13 Table 2 : Rheumatoid Arthritis , Therapeutics , Global , All Pipeline Products , Discovery Phase , 2014 94 Table 3 : Rheumatoid Arthritis , Therapeutics , Global , All Pipeline Products , Preclinical Phase , 2014 98
Table 4 : Rheumatoid Arthritis , Therapeutics , Global , All Pipeline Products , IND / CTA-Filed Phase , 2014 108
Read Complete Report with TOC @ http :// www . radiantinsights . com / research / rheumatoidarthritis-market-to-2020-a-crowded-market-characterized-by-modest-growth
Table 5 : Rheumatoid Arthritis , Therapeutics , Global , All Pipeline Products , Phase I , 2014 109 Table 6 : Rheumatoid Arthritis , Therapeutics , Global , All Pipeline Products , Phase II , 2014 111 Table 7 : Rheumatoid Arthritis , Therapeutics , Global , All Pipeline Products , Phase III , 2014 113 Table 8 : Rheumatoid Arthritis , Therapeutics Market , Global , Market Forecast , 2013 – 2020 115 Table 9 : Rheumatoid Arthritis , Therapeutics Market , US , Market Forecast , 2013 – 2020 115 Table 10 : Rheumatoid Arthritis , Therapeutics Market , Canada , Market Forecast , 2013 – 2020 Table 11 : Rheumatoid Arthritis , Therapeutics Market , UK , Market Forecast , 2013 – 2020 116 Table 12 : Rheumatoid Arthritis , Therapeutics Market , Germany , Market Forecast , 2013 – 2020
Table 13 : Rheumatoid Arthritis , Therapeutics Market , France , Market Forecast , 2013 – 2020 Table 14 : Rheumatoid Arthritis , Therapeutics Market , Italy , Market Forecast , 2013 – 2020 118